Innoviva, Inc. - Common Stock · Transaction Mar 25, 2025 · Filed Apr 23, 2025 · $250,001 to $500,000
NASDAQ NMS - GLOBAL MARKET · INVA
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Innoviva Inc
Pharmaceuticals
$20.51
Veridion Score
BETAMEDIUM CONF · 5/6 factorsFri Aug 7 · last completed session · Pre-market · regular session opens 9:30 ET · INVA
MethodologyINVA
Innoviva Inc
Fri Aug 7 · last completed session · Pre-market · regular session opens 9:30 ET
BUY BIAS
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
71/ 100
Veridion Score
BUY BIAS · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Fri Aug 7 · last completed session · Pre-market · regular session opens 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is INVA moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Innoviva Inc
PHARMACEUTICAL PREPARATIONSListed since
2004
Employees
159
Country
US
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$20.51
Last session
Day high
$20.51
Last session
Day low
$20.51
Last session
Previous close
$20.51
52W high
$24.24
-15.39% from high
52W low
$16.67
51% of range
Market cap
$1.5B
P/E
2.94×
EPS
$2.93
Beta
-0.22
Shares out
72.2M
Avg volume
849.7K
VWAP
$20.51
Last session
Price history computed in-house
1W
-1.25%
1M
-7.78%
3M
-9.81%
1Y
+11.83%
YTD
+2.60%
SMA 50 $22.02 · below
SMA 200 $21.61 · below
52W position 51%
INVA overview
Veridion Score
71
5 of 6 factors measured
Congress receipts
2
George Whitesides · Sale
13F holders
None on file
Related filings and maps
Public disclosures
Congress activity in INVA
Official filing ↗
INVA · Transaction Mar 24, 2025 · Filed Apr 23, 2025 · $50,001 to $100,000
Federal contracts
INVA contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for INVA in this window.
Lobbying spend
INVA lobbying filings, year to date.
Registered lobbying filings matched to Innoviva Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for INVA in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for INVA.
Options
Sovereign unlock shows live options positioning for INVA.